Comparison of four-combination chemother
โ
Takuma Nemoto; John Horton; Richard Simon; Thomas L. Dao; Dutzu Rosner; Thomas C
๐
Article
๐
1982
๐
John Wiley and Sons
๐
English
โ 455 KB
๐ 1 views
In 126 postmenopausal women with metastatic breast cancer, four chemotherapeutic combination programs were tested. Patients were stratified and randomized to one o f the four programs: (1) fluorouracil, cytoxan and prednisone (CFP): (2) fluorouracil, cytoxan and Adriamycin (CAF); (3) cytoxan and Adr